Consistent with previous Kruskal—Wallis test (Table 1), univariate survival analysis revealed that meningioma patients with high RLIP76 expression would more likely have tumor recurrence as compared with those with low RLIP76 expression(P = 0.007, Table 2). The gene discussed is RALBP1; the disease is neoplasm.